CONSIDERATIONS TO KNOW ABOUT LEVITRABIS.COM

Physicians ought to think about whether their sufferers with underlying NAION risk variables may very well be adversely impacted by utilization of PDE5 inhibitors. Individuals who have previously knowledgeable NAION are at increased risk of NAION recurrence. As a result, PDE5 inhibitors, including LEVITRA, must be used with caution in these clients